Exhibit 10.20 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.Agreement • March 2nd, 2005 • Dragon Pharmaceutical Inc • Pharmaceutical preparations
Contract Type FiledMarch 2nd, 2005 Company Industry
Exhibit 10.18 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.Collaboration Agreement • March 2nd, 2005 • Dragon Pharmaceutical Inc • Pharmaceutical preparations • British Columbia
Contract Type FiledMarch 2nd, 2005 Company Industry Jurisdiction
Exhibit 10.21 Portions redacted. * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.Dragon Pharmaceutical Inc • March 2nd, 2005 • Pharmaceutical preparations
Company FiledMarch 2nd, 2005 Industry
Exhibit 10.19 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Agent Agreement THIS...Agent Agreement • March 2nd, 2005 • Dragon Pharmaceutical Inc • Pharmaceutical preparations • Hong Kong
Contract Type FiledMarch 2nd, 2005 Company Industry Jurisdiction
Exhibit 10.22 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. TECHNOLOGY TRANSFER...Dragon Pharmaceutical Inc • March 2nd, 2005 • Pharmaceutical preparations
Company FiledMarch 2nd, 2005 Industry
Exhibit 10.24 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. TECHNOLOGY TRANSFER...Dragon Pharmaceutical Inc • March 2nd, 2005 • Pharmaceutical preparations
Company FiledMarch 2nd, 2005 Industry
Exhibit 10.23 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Manufacturing...Dragon Pharmaceutical Inc • March 2nd, 2005 • Pharmaceutical preparations
Company FiledMarch 2nd, 2005 Industry